The present study finds that BOLD-LFO power is inversely related to plasma pTau217 levels in APOE4 carriers but not in non-carriers, suggesting a role for the APOE4 gene in the association between BOLD-LFOs and AD pathophysiological change. This evidence concerns the gene APOE and Alzheimer disease.